Clyde & Co advised Chronos Therapeutics Limited on the deal. Evgen Pharma plc (AIM:EVG) agreed to acquire Chronos Therapeutics Ltd. for £3.4 million. The total consideration...
Clyde & Co advised Chronos Therapeutics Limited on the deal. Evgen Pharma plc (AIM:EVG) agreed to acquire Chronos Therapeutics Ltd. for £3.4 million. The total consideration...
You must be a Standard 1 Year member to access this content.